Brief: Epredia Receives U.S. FDA 510(K) Clearance For The E1000 DX™ Digital Pathology Solution
04/03/2025 13:17
March 4 (Reuters) - PHC Holdings Corp 6523.T: EPREDIA RECEIVES U.S. FDA 510(K) CLEARANCE FOR THE E1000 DX™ DIGITAL PATHOLOGY SOLUTION DESIGNED TO IMPROVE LABORATORY WORKFLOW IN CANCER DIAGNOSTICS Source text: ID:nBw53Fgjga Further company coverage: 6523.T (Reuters.Briefs@thomsonreuters.com)
Recent news on PHC Holdings
See all newsTable: Phc Holdings -2025/26 group results (IFRS)
Table: Phc Holdings -9-MTH group results (IFRS)
Table: Phc Holdings 6-MTH group results (IFRS)
Brief: PHC Holdings Corp - Notice Regarding Signing Of Memorandum Of Understanding On Business Transfer Of A Consolidated Subsidiary
Table: Phc Holdings -Q1 group results (IFRS)